RxDoctor Payments Data

Chiemeka Onyima, MD

Anesthesiology · Washington, DCNPI 1215460076

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,872 of the $2,570 with a category attached, or 72.8%. 12 manufacturers reported payments, led by Medtronic at 26.4% of the total. Among anesthesiology clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,570in general payments, 2019–2025

Across 44 payments — averaging $58.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$680
  • Curonix LLC$524
  • Nevro Corp.$403
  • Globus Medical$378
  • Abbott$160
  • Avanos Medical$133
  • plus $292 from 6 others

What the payments were for

  • Travel & lodging$69827%
  • Food & beverage$1,87273%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,570 in reported general payments places this provider in the 95th percentile of 253 anesthesiology providers in District of Columbia.

See all anesthesiology providers in District of Columbia

Medicare billing

Part B allowed, 2024
$156,704
Medicare patients
405
Services billed
3,690

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin692$8,539
Lidocaine195$5,528
Pregabalin243$4,380
Duloxetine Hcl140$2,966
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen136$2,404
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen96$1,540
Tizanidine Hcl100$1,383
Cyclobenzaprine Hcl92$1,148
Tramadol Hcl ErTramadol Hcl16$1,091
Oxycodone Hcl62$946
Celecoxib30$884
Tramadol Hcl119$857
Amitriptyline Hcl82$689
Ibuprofen58$549
Morphine Sulfate ErMorphine Sulfate27$539

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →